Tandem Diabetes Care, Inc. (TNDM) Free Cash Flow

Tandem Diabetes Care, Inc. (TNDM) free cash flow history and trends. Track FCF in Excel with MarketXLS.

Free Cash Flow Data

PeriodFree Cash Flow (USD)
2016-12-31-$70.10M
2017-12-31-$71.85M
2018-12-31-$11.30M
2019-12-31$22.36M
2020-12-31-$2.74M
2021-12-31$87.85M
2022-12-31$16.37M
2023-12-31-$58.61M
2024-12-31$4.99M
2025-12-31-$29.67M

How TNDM compares with sector peers

SymbolCompanyFree cash flow (latest fiscal year)
AXGNAxogen Inc.-$4.78M
PMCBPharmaCyte Biotech Inc.-$5.15M
SPROSpero Therapeutics Inc.-$12.62M
HRTXHeron Therapeutics Inc.-$27.91M
IARTIntegra LifeSciences Holdings Corporation-$45.25M

These are five companies in the same sector as TNDM with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Tandem Diabetes Care, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Free_Cash_Flow("TNDM", 2024)

BUY NOW